RxDoctor Payments DataLook up a doctor →

Anna Wiygul

Family · Oxford, MSNPI 1619496403

Payments from drug & device makers

$14,582in general payments, 2019–2025

Across 777 payments — averaging $18.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novartis$1K
  • Merck$999
  • Johnson & Johnson$909
  • E.r. Squibb & Sons, L.L.C.$775
  • Pfizer$639
  • Lilly USA, LLC$589
  • plus $9K from 54 others

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Novartis82$1,385
Merck47$999
Johnson & Johnson(2 entities)57$909
E.r. Squibb & Sons, L.L.C.51$775
Pfizer41$639
Lilly USA, LLC32$589
Bristol Myers Squibb29$551
Gilead27$533
AstraZeneca(2 entities)29$524
Takeda Pharmaceuticals U.S.A., Inc.21$490
Incyte Corporation22$431
Seagen Inc.22$429
Karyopharm Therapeutics Inc.8$428
Eisai Inc.23$387
Genentech USA, Inc.19$375
Pharmacyclics LLC, An Abbvie Company19$359
AbbVie15$347
GSK20$346
Exelixis Inc.20$345
Daiichi Sankyo Inc.16$330
Amgen17$289
Astellas Pharma US Inc10$214
Beigene USA, Inc.10$200
Rigel Pharmaceuticals, Inc.10$163
AVEO Pharmaceuticals, Inc.8$159
Bayer8$157
Pharmacosmos Therapeutics Inc.8$157
EMD Serono, Inc.9$147
Regeneron Healthcare Solutions, Inc.6$131
Taiho Oncology, Inc.8$129
Adaptive Biotechnologies Corporation6$128
Sanofi5$116
Tersera Therapeutics LLC5$104
Intuitive Surgical1$103
Jazz Pharmaceuticals Inc.4$98
Array Biopharma Inc5$96
Sobi, Inc4$95
Dendreon Pharmaceuticals LLC4$93
Mirati Therapeutics, Inc.5$77
G1 Therapeutics, Inc.5$74
Tempus AI, Inc3$67
Springworks Therapeutics, Inc.2$54
Caris MPI, Inc.3$46
AMAG Pharmaceuticals, Inc.3$41
Blueprint Medicines Corporation2$41
Boehringer Ingelheim2$39
Servier Pharmaceuticals LLC2$31
Pharmaessentia USA Corporation2$30
Alnylam Pharmaceuticals Inc.1$28
Puma Biotechnology, Inc.2$25
Deciphera Pharmaceuticals Inc.1$25
Recordati_rare_diseases_inc.1$23
Dova Pharmaceuticals1$20
Genmab U.S., Inc.1$19
Beone Medicines USA, Inc.1$18
Kyowa Kirin, Inc.1$18
Sanofi-aventis U.S. LLC1$17
Ipsen Biopharmaceuticals, Inc1$16
Agios Pharmaceuticals, Inc.1$16
Coherus Oncology, Inc.1$15

How this compares

$14,582 in reported general payments places this provider in the 95th percentile of 3,007 family providers in Mississippi.

See all family providers in Mississippi

Medicare billing

Part B allowed, 2024
$43,104
Medicare patients
326
Services billed
717

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other family in Oxford

See the full list for Mississippi

Where these figures come from

Is this you, or does something look wrong? →